Background & Aims Many patients with chronic hepatitis B (CHB) may not conform to any of
the defined phases and hence are classified as indeterminate. We aimed to characterize the …

Abstract Background Chronic hepatitis B (CHB) and fatty liver (FL) are common, natural
history data on concurrent FL and CHB (FL-CHB) are limited. This study aimed to evaluate …

Objectives: Hepatitis C virus (HCV) infection is a well-documented risk factor for
hepatocellular carcinoma (HCC). Seven HCV genotypes have been classified, and the …

Background & Aims It is unclear whether drugs used to treat chronic hepatitis B virus (HBV)
infection cause significant renal impairment. We compare adjusted mean estimated …

Background & Aims The American Association for the Study of Liver Diseases (AASLD)
guidelines for treatment of chronic hepatitis B virus (HBV) infection have changed with time …

Background & aims Nonalcoholic fatty liver disease (NAFLD) and chronic hepatitis B (CHB)
are common liver diseases. Concurrent NAFLD may affect antiviral treatment outcomes in …

Metabolic‐associated fatty liver disease (MAFLD) is a major cause of liver‐related
complications, including hepatocellular carcinoma (HCC). While MAFLD‐related HCC is …

Introduction: Accurate identification of patients with cirrhosis is important for research using
administrative databases. We aimed to examine the accuracy of several major ICD-10 codes …

Goals To examine the role that autoantibodies (auto-abs) play in chronic hepatitis C virus
(HCV) regarding demographics, presence of extrahepatic manifestations and long-term …

Liver cirrhosis is one of the leading causes of death in adults worldwide. It is highly prevalent
in developing countries and is growing in prevalence in developed countries mostly …